PL370772A1 - Synteza analogów cyklosporyny - Google Patents
Synteza analogów cyklosporynyInfo
- Publication number
- PL370772A1 PL370772A1 PL37077202A PL37077202A PL370772A1 PL 370772 A1 PL370772 A1 PL 370772A1 PL 37077202 A PL37077202 A PL 37077202A PL 37077202 A PL37077202 A PL 37077202A PL 370772 A1 PL370772 A1 PL 370772A1
- Authority
- PL
- Poland
- Prior art keywords
- isomers
- isa
- cyclosporine
- derivatives
- mixtures
- Prior art date
Links
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical class CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 title abstract 5
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 5
- 108010036941 Cyclosporins Proteins 0.000 abstract 2
- 229930182912 cyclosporin Natural products 0.000 abstract 2
- 230000037361 pathway Effects 0.000 abstract 2
- 230000000707 stereoselective effect Effects 0.000 abstract 2
- 230000001988 toxicity Effects 0.000 abstract 2
- 231100000419 toxicity Toxicity 0.000 abstract 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 abstract 1
- 229930105110 Cyclosporin A Natural products 0.000 abstract 1
- 108010036949 Cyclosporine Proteins 0.000 abstract 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 abstract 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 abstract 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 abstract 1
- 238000007239 Wittig reaction Methods 0.000 abstract 1
- 229910052796 boron Inorganic materials 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 229910052744 lithium Inorganic materials 0.000 abstract 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 abstract 1
- 125000002524 organometallic group Chemical group 0.000 abstract 1
- 229910052710 silicon Inorganic materials 0.000 abstract 1
- 239000010703 silicon Substances 0.000 abstract 1
- 229910052719 titanium Inorganic materials 0.000 abstract 1
- 239000010936 titanium Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- C07K7/645—Cyclosporins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Nanotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34620101P | 2001-10-19 | 2001-10-19 | |
| US37059602P | 2002-04-05 | 2002-04-05 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL370772A1 true PL370772A1 (pl) | 2005-05-30 |
| PL210841B1 PL210841B1 (pl) | 2012-03-30 |
Family
ID=26994746
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL370772A PL210841B1 (pl) | 2001-10-19 | 2002-10-17 | Sposób wytwarzania mieszaniny izomerów (E) i (Z) ISATX247 |
| PL392749A PL210795B1 (pl) | 2001-10-19 | 2002-10-17 | Sposób wytwarzania mieszaniny ISATX247 wzbogaconej w izomer (E), sposób wytwarzania mieszaniny ISATX247 wzbogaconej w izomer (Z), sposób stereoselektywnej syntezy izomeru (E) ISATX247, sposób stereoselektywnej syntezy izomeru (Z) ISATX247 i sposób wytwarzania mieszaniny izomerów ISATX247 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL392749A PL210795B1 (pl) | 2001-10-19 | 2002-10-17 | Sposób wytwarzania mieszaniny ISATX247 wzbogaconej w izomer (E), sposób wytwarzania mieszaniny ISATX247 wzbogaconej w izomer (Z), sposób stereoselektywnej syntezy izomeru (E) ISATX247, sposób stereoselektywnej syntezy izomeru (Z) ISATX247 i sposób wytwarzania mieszaniny izomerów ISATX247 |
Country Status (27)
| Country | Link |
|---|---|
| US (13) | US7141648B2 (pl) |
| EP (2) | EP1714977B1 (pl) |
| JP (3) | JP4261355B2 (pl) |
| KR (2) | KR100982466B1 (pl) |
| CN (1) | CN100334106C (pl) |
| AT (2) | ATE425178T1 (pl) |
| AU (2) | AU2002331509B2 (pl) |
| BR (1) | BRPI0213658A8 (pl) |
| CA (1) | CA2461740C (pl) |
| CO (1) | CO5580836A2 (pl) |
| CY (1) | CY1105111T1 (pl) |
| DE (2) | DE60231570D1 (pl) |
| DK (2) | DK1714977T3 (pl) |
| ES (2) | ES2266564T3 (pl) |
| HR (2) | HRP20040355B1 (pl) |
| IL (3) | IL160763A0 (pl) |
| MA (1) | MA27293A1 (pl) |
| MX (1) | MXPA04003625A (pl) |
| NO (1) | NO332459B1 (pl) |
| NZ (1) | NZ531944A (pl) |
| PL (2) | PL210841B1 (pl) |
| PT (2) | PT1714977E (pl) |
| RU (1) | RU2321593C9 (pl) |
| SI (1) | SI1436321T1 (pl) |
| TN (1) | TNSN04068A1 (pl) |
| WO (1) | WO2003033526A2 (pl) |
| ZA (1) | ZA200402269B (pl) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030220234A1 (en) * | 1998-11-02 | 2003-11-27 | Selvaraj Naicker | Deuterated cyclosporine analogs and their use as immunodulating agents |
| US7141648B2 (en) | 2001-10-19 | 2006-11-28 | Isotechnika Inc. | Synthesis of cyclosporin analogs |
| PL210697B1 (pl) * | 2001-10-19 | 2012-02-29 | Isotechnika Inc | Kompozycja zawierająca mieszaninę izomerów analogu cyklosporyny i zastosowanie tej mieszaniny |
| CA2518265A1 (en) | 2003-03-17 | 2004-09-30 | Albany Molecular Research, Inc. | Novel cyclosporins |
| TW200505946A (en) * | 2003-04-08 | 2005-02-16 | Hoffmann La Roche | Process for preparation of cyclosporin a analog |
| US20040266669A1 (en) * | 2003-06-20 | 2004-12-30 | Wu Frank X. H. | Cyclosporin derivatives for the treatment of immune disorders |
| WO2006014872A2 (en) * | 2004-07-29 | 2006-02-09 | Amr Technology, Inc. | Novel processes for stereoselective synthesis of trans isatx 247 |
| WO2006039163A2 (en) | 2004-09-29 | 2006-04-13 | Amr Technology, Inc. | Cyclosporin alkyne analogues and their pharmaceutical uses |
| JP2008514702A (ja) * | 2004-09-29 | 2008-05-08 | エーエムアール テクノロジー インコーポレイテッド | 新規シクロスポリン類似体およびそれらの薬学的使用 |
| WO2006041631A2 (en) * | 2004-10-06 | 2006-04-20 | Amr Technology, Inc. | Novel cyclosporin alkynes and their utility as pharmaceutical agents |
| CA2592343A1 (en) * | 2004-12-17 | 2006-06-22 | Isotechnika Inc. | Metabolites of cyclosporin analogs |
| EP1928807A4 (en) * | 2005-09-02 | 2011-05-04 | Picobella Llc | ONCOGENIC REGULATORS RNA FOR DIAGNOSIS AND THERAPY |
| US7459280B2 (en) * | 2006-02-27 | 2008-12-02 | Picobella, Llc | Methods for diagnosing and treating kidney cancer |
| US7696165B2 (en) | 2006-03-28 | 2010-04-13 | Albany Molecular Research, Inc. | Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders |
| US7696166B2 (en) * | 2006-03-28 | 2010-04-13 | Albany Molecular Research, Inc. | Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders |
| US20070232532A1 (en) * | 2006-03-28 | 2007-10-04 | Amr Technology, Inc. | Use of cyclosporin alkene analogues for preventing or treating viral-induced disorders |
| US20080267977A1 (en) * | 2007-04-26 | 2008-10-30 | Friedrich-Alexander University Of Erlangen-Nuremberg | Combined immunological agent and sensitizing agent for the treatment of cancer |
| JP5668476B2 (ja) * | 2007-10-08 | 2015-02-12 | オーリニア・ファーマシューティカルズ・インコーポレイテッドＡｕｒｉｎｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． | カルシニューリン阻害剤またはｍＴＯＲ阻害剤を含む眼科用組成物 |
| EP2151450A1 (de) * | 2008-07-29 | 2010-02-10 | Sandoz AG | Verfahren zur Aufarbeitung von mikrobiologisch hergestellten zyklischen Oligopeptiden |
| US20130190223A1 (en) * | 2008-07-30 | 2013-07-25 | Isotechnika Pharma Inc. | Nonimmunosuppressive cyclosporine analogue molecules |
| DE102008060549A1 (de) | 2008-12-04 | 2010-06-10 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung |
| KR20110111321A (ko) | 2009-01-30 | 2011-10-10 | 이난타 파마슈티칼스, 인코포레이티드 | Ｃ형 간염을 예방하거나 치료하기 위한 사이클로스포린 유사체 |
| US8481483B2 (en) | 2009-02-19 | 2013-07-09 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogues |
| MX338355B (es) | 2009-06-09 | 2016-04-13 | Aurinia Pharmaceuticals Inc | Sistemas de suministro de farmaco topico para uso oftalmico. |
| US8349312B2 (en) | 2009-07-09 | 2013-01-08 | Enanta Pharmaceuticals, Inc. | Proline substituted cyclosporin analogues |
| US8685917B2 (en) | 2009-07-09 | 2014-04-01 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogues |
| US8367053B2 (en) | 2009-07-09 | 2013-02-05 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogues |
| GB0912584D0 (en) * | 2009-07-20 | 2009-08-26 | Ucl Business Plc | Cyclosporin conjugates |
| US8623814B2 (en) | 2010-02-23 | 2014-01-07 | Enanta Pharmaceuticals, Inc. | Antiviral agents |
| KR102011339B1 (ko) | 2010-12-15 | 2019-08-16 | 콘트라빌 파마슈티컬스, 인코퍼레이티드 | 아미노산 1 및 3에서 변형된 사이클로스포린 유사체 분자 |
| WO2012103520A1 (en) * | 2011-01-28 | 2012-08-02 | Board Of Regents Of The University Of Nebraska | Methods and compositions for modulating cyclophilin d |
| US10429712B2 (en) | 2012-04-20 | 2019-10-01 | View, Inc. | Angled bus bar |
| WO2012145426A1 (en) | 2011-04-18 | 2012-10-26 | The Trustees Of Columbia University In The City Of New York | Methods to treat cancer using cyclosporine and cyclosporine derivatives |
| CN103501812A (zh) | 2011-04-29 | 2014-01-08 | 西莱克塔生物科技公司 | 用于过敏症治疗的致耐受性合成纳米载体 |
| AR090964A1 (es) * | 2012-05-09 | 2014-12-17 | Novartis Ag | Proceso para la elaboracion de undecapeptidos ciclicos |
| EP3263587A1 (en) | 2012-06-01 | 2018-01-03 | Allergan, Inc. | Cyclosporin a analogs |
| EP2705856A1 (en) | 2012-09-07 | 2014-03-12 | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. | Compounds for the treatment of neurodegenerative disorders |
| WO2014085623A1 (en) | 2012-11-28 | 2014-06-05 | Enanta Pharmaceuticals, Inc. | Novel [n-me-4-hydroxyleucine]-9-cyclosporin analogues |
| ES2834964T3 (es) | 2013-04-01 | 2021-06-21 | Allergan Inc | Sistema de administración de fármacos mediante microesferas para liberación intraocular sostenida |
| CN118370823A (zh) | 2013-05-03 | 2024-07-23 | 西莱克塔生物科技公司 | 用于降低的或增强的药效学作用的致耐受性合成纳米载体和治疗性大分子 |
| TWI685706B (zh) | 2013-06-18 | 2020-02-21 | 唯景公司 | 非矩形之電致變色裝置 |
| RU2016110247A (ru) | 2013-08-26 | 2017-10-02 | Энанта Фармасьютикалс, Инк. | Аналоги циклоспорина для предупреждения или лечения гепатита с |
| WO2016037162A1 (en) | 2014-09-07 | 2016-03-10 | Selecta Biosciences, Inc. | Methods and compositions for attenuating anti-viral transfer vector immune responses |
| WO2016073480A1 (en) | 2014-11-03 | 2016-05-12 | Enanta Pharmaceuticals, Inc. | Novel cyclosporin analogues for preventing or treating hepatitis c infection |
| AU2015364524A1 (en) * | 2014-12-17 | 2017-07-13 | Verrica Pharmaceuticals, Inc. | Commercially viable synthesis of cantharidin and bioactive cantharidin derivatives |
| TW201639873A (zh) | 2015-01-08 | 2016-11-16 | 歐樂根公司 | Ｍｅｂｍｔ側鏈已環化之環孢菌素衍生物 |
| CN106554392B (zh) * | 2016-11-21 | 2019-10-25 | 石家庄中天生物技术有限责任公司 | 一种高纯度环孢菌素衍生物stg-175的制备方法 |
| HUE072005T2 (hu) | 2017-03-11 | 2025-10-28 | Cartesian Therapeutics Inc | Gyulladásgátlókkal és immunszupresszánst tartalmazó szintetikus nanohordozókkal történõ kombinált kezeléssel összefüggõ eljárások és készítmények |
| US20190224275A1 (en) | 2017-05-12 | 2019-07-25 | Aurinia Pharmaceuticals Inc. | Protocol for treatment of lupus nephritis |
| US10286036B2 (en) | 2017-05-12 | 2019-05-14 | Aurinia Pharmaceuticals Inc. | Protocol for treatment of lupus nephritis |
| IL314274A (en) | 2017-06-06 | 2024-09-01 | Verrica Pharmaceuticals Inc | Treatment of cutaneous disorders |
| USD900312S1 (en) | 2017-06-15 | 2020-10-27 | Verrica Pharmaceuticals, Inc. | Applicator |
| MX2019014908A (es) | 2017-06-15 | 2020-02-13 | Verrica Pharmaceuticals Inc | Dispositivos y metodos para el tratamiento de trastornos de la superficie corporal. |
| KR102765631B1 (ko) | 2017-10-04 | 2025-02-11 | 베리카 파마슈티컬스 인크. | 칸타리딘의 합성 |
| US11584779B2 (en) | 2018-10-19 | 2023-02-21 | Teva Pharmaceuticals International Gmbh | Solid state forms of voclosporin |
| CA3181952A1 (en) | 2020-05-07 | 2021-11-11 | Aurinia Pharmaceuticals Inc. | Methods of treating or preventing coronavirus infection |
| EP4201952A1 (en) | 2021-12-21 | 2023-06-28 | Curia Spain, S.A.U. | Process for the controlled synthesis of voclosporin |
| WO2025119925A1 (en) | 2023-12-05 | 2025-06-12 | Medichem, S.A. | Process for preparing voclosporin |
Family Cites Families (201)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US525590A (en) * | 1894-09-04 | canda | ||
| US4210581A (en) * | 1975-11-04 | 1980-07-01 | Sandoz Ltd. | Organic compounds |
| CH614931A5 (pl) * | 1975-11-04 | 1979-12-28 | Sandoz Ag | |
| US4117118A (en) | 1976-04-09 | 1978-09-26 | Sandoz Ltd. | Organic compounds |
| DK25877A (da) | 1977-01-21 | 1978-08-15 | Nordisk Insulinlab | Fremgangsmaade til udvinding af renset albumin fra blodplasma |
| US4256108A (en) * | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| US4160452A (en) * | 1977-04-07 | 1979-07-10 | Alza Corporation | Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina |
| DE2819094A1 (de) * | 1977-05-10 | 1978-11-23 | Sandoz Ag | Cyclosporin-derivate, ihre verwendung und herstellung |
| CH630061A5 (en) | 1977-05-10 | 1982-05-28 | Sandoz Ag | Process for the preparation of an antibiotic derivative |
| CH628022A5 (en) | 1977-05-10 | 1982-02-15 | Sandoz Ag | Process for the preparation of an antibiotic derivative |
| CH630062A5 (en) | 1977-05-23 | 1982-05-28 | Sandoz Ag | Process for the preparation of an antibiotic derivative |
| SE448386B (sv) * | 1978-10-18 | 1987-02-16 | Sandoz Ag | Nya cyklosporinderivat, forfarande for framstellning av dem samt farmaceutisk komposition innehallande dem |
| US4201771A (en) | 1979-03-12 | 1980-05-06 | Merck & Co., Inc. | Antibiotic A43F |
| IE54936B1 (en) * | 1980-02-14 | 1990-03-28 | Sandoz Ltd | A method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production |
| US4396542A (en) * | 1980-02-14 | 1983-08-02 | Sandoz Ltd. | Method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production |
| US4265874A (en) * | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| FR2487198A1 (fr) | 1980-07-28 | 1982-01-29 | Berri Balzac Sa | Nouvelle substance immuno-suppressive, son procede d'isolement et son application en therapeutique |
| US4304641A (en) | 1980-11-24 | 1981-12-08 | International Business Machines Corporation | Rotary electroplating cell with controlled current distribution |
| DE3260468D1 (en) | 1981-01-09 | 1984-09-06 | Sandoz Ag | Novel cyclosporins |
| CH667274A5 (de) | 1984-03-23 | 1988-09-30 | Sandoz Ag | Cyclosporine, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen. |
| NZ212051A (en) | 1984-05-18 | 1988-10-28 | Univ Australian | Immune response suppression; certain epipolythio- dioxopiperazine derivatives and their preparation |
| US5639724A (en) | 1984-07-24 | 1997-06-17 | Sandoz Ltd. | Cyclosporin galenic forms |
| GB8422253D0 (en) | 1984-09-04 | 1984-10-10 | Sandoz Ltd | Organic compounds |
| AU589917B2 (en) | 1984-10-04 | 1989-10-26 | Novartis Ag | Monoclonal antibodies to cyclosporins |
| US5169773A (en) | 1984-10-04 | 1992-12-08 | Sandoz Ltd. | Monoclonal antibodies to cyclosporins |
| EP0194972B1 (en) | 1985-03-11 | 1992-07-29 | Sandoz Ag | Novel cyclosporins |
| US5047512A (en) | 1985-05-03 | 1991-09-10 | Handschumacher Robert E | Immobilized cyclophilin and methods of using such |
| DE3531597A1 (de) | 1985-09-04 | 1987-03-05 | Bioferon Biochem Substanz | Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur behandlung psoriatischer erkrankungen |
| US4765980A (en) | 1986-04-28 | 1988-08-23 | International Minerals & Chemical Corp. | Stabilized porcine growth hormone |
| CH670644A5 (pl) * | 1986-12-18 | 1989-06-30 | Lonza Ag | |
| US4764503A (en) | 1986-11-19 | 1988-08-16 | Sandoz Ltd. | Novel cyclosporins |
| US4963683A (en) * | 1986-12-18 | 1990-10-16 | Sri International | Process for preparing polyoxa tetracyclic compounds |
| HU205861B (en) | 1986-12-19 | 1992-07-28 | Sandoz Ag | Process for producing hydrosole of pharmaceutically effective material |
| US5084441A (en) | 1987-03-04 | 1992-01-28 | Shaw Jack M | Acetylated low density lipoproteins: a delivery system to phagocytic cells for stimulating immunologic response and host resistance |
| US5427960A (en) | 1987-03-27 | 1995-06-27 | Abbott Laboratories | Fluorescence polarization assay for cyclosporin A and metabolites and related immunogens and antibodies |
| US5239057A (en) * | 1987-03-27 | 1993-08-24 | Abbott Laboratories | Fluorescence polarization assay for cyclosporin a and metabolites and related immunogens and antibodies |
| EP0283801A3 (en) | 1987-03-27 | 1990-05-30 | Abbott Laboratories | Fluorescence polarization assay for cyclosporin a and metabolites and related immunogens and antibodies |
| US4885276A (en) | 1987-06-03 | 1989-12-05 | Merck & Co., Inc. | Cyclosporin analogs with modified "C-9 amino acids" |
| US4798823A (en) | 1987-06-03 | 1989-01-17 | Merck & Co., Inc. | New cyclosporin analogs with modified "C-9 amino acids" |
| JP2577049B2 (ja) | 1987-06-04 | 1997-01-29 | 三共株式会社 | シクロスポリン製剤 |
| DE3884470T2 (de) * | 1987-06-17 | 1994-03-10 | Sandoz Ag | Cyclosporine und deren Benutzung als Arzneimittel. |
| EP0296123B1 (en) | 1987-06-19 | 1994-08-31 | Sandoz Ag | Cyclic peptolides |
| GB2206119B (en) | 1987-06-22 | 1990-10-31 | Merck & Co Inc | A new cyclosporin derivative with modified "8-amino acid" |
| EP0373260B1 (en) | 1987-06-22 | 1994-03-09 | Merck & Co. Inc. | Cyclosporin derivatives with modified "8-amino acid" |
| GB8717300D0 (en) | 1987-07-22 | 1987-08-26 | Nat Res Dev | Cyclosporins |
| GB8717299D0 (en) | 1987-07-22 | 1987-08-26 | Nat Res Dev | Peptides |
| GB2207678A (en) | 1987-08-03 | 1989-02-08 | Merck & Co Inc | Novel immunosuppressive fluorinated cyclosporin analogs |
| US5227467A (en) | 1987-08-03 | 1993-07-13 | Merck & Co., Inc. | Immunosuppressive fluorinated cyclosporin analogs |
| US4963362A (en) | 1987-08-07 | 1990-10-16 | Regents Of The University Of Minnesota | Freeze-dried liposome mixture containing cyclosporin |
| EP0391909B1 (en) | 1987-09-03 | 1994-08-17 | The University Of Georgia Research Foundation, Inc. | Ocular cyclosporin composition |
| US4839342A (en) | 1987-09-03 | 1989-06-13 | University Of Georgia Research Foundation, Inc. | Method of increasing tear production by topical administration of cyclosporin |
| US5089390A (en) | 1987-09-04 | 1992-02-18 | Syntex (U.S.A.) Inc. | 2-methyl-4-hexene- and 2-methyl-4-heptene-1,2-diol derivatives |
| US4868157A (en) | 1987-10-05 | 1989-09-19 | Merck & Co., Inc. | Dipeptidyl 2-amino-1,2-dideoxy-D-glucose derivatives as host resistance enhancers in AIDS-immunocompromised hosts and methods of use |
| US4868155A (en) | 1987-10-05 | 1989-09-19 | Merck & Co., Inc. | Dipeptidyl 4-0-,6-0-acyl-2-amino-2-deoxy-D-glucose compositions and methods of use in AIDS-immunocompromised human hosts |
| US4866036A (en) | 1987-10-05 | 1989-09-12 | Merck & Co., Inc. | Dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose compositions and methods of use in aids-immunocompromised human hosts |
| US4914188A (en) | 1987-11-16 | 1990-04-03 | Merck & Co., Inc. | Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin |
| US5236899A (en) | 1987-11-16 | 1993-08-17 | Merck & Co., Inc. | 6-position cyclosporin a analogs as modifiers of cytotoxic drug resistance |
| GB8729153D0 (en) | 1987-12-14 | 1988-01-27 | Efamol Ltd | Fatty acid compositions |
| US5693760A (en) | 1988-04-14 | 1997-12-02 | Incyte Pharmaceuticals, Inc. | Method of causing selective immunosuppression using HL-60 related lectins |
| DE68907483T2 (de) | 1988-04-21 | 1993-10-21 | Leo Pharm Prod Ltd | Vitamin d analoge. |
| JPH0774799B2 (ja) | 1988-04-28 | 1995-08-09 | 積水化学工業株式会社 | 血中成分の測定法 |
| AU641361B2 (en) | 1988-05-02 | 1993-09-23 | Zynaxis Technologies, Incorporated | Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles |
| US5013719A (en) | 1988-05-13 | 1991-05-07 | Merrell Dow Pharmaceuticals Inc. | Method of effecting immunosuppression |
| DE3927804A1 (de) | 1988-08-24 | 1990-03-01 | Boehringer Ingelheim Kg | Verwendung von paf-antagonisten zur behandlung von autoimmunerkrankungen |
| EP0436020A4 (en) | 1988-09-14 | 1992-03-25 | Yoshitomi Pharmaceutical Industries, Ltd. | Immunosuppressant |
| KR0148748B1 (ko) | 1988-09-16 | 1998-08-17 | 장 크라메르, 한스 루돌프 하우스 | 사이클로스포린을 함유하는 약학조성물 |
| US5342625A (en) | 1988-09-16 | 1994-08-30 | Sandoz Ltd. | Pharmaceutical compositions comprising cyclosporins |
| JPH02124100A (ja) | 1988-11-02 | 1990-05-11 | Tonen Corp | プロリルイソメラーゼの使用方法 |
| US5632991A (en) | 1988-11-14 | 1997-05-27 | Brigham & Women's Hospital | Antibodies specific for E-selectin and the uses thereof |
| AU630901B2 (en) | 1988-12-02 | 1992-11-12 | Children's Research Institute | Cyclosporine binding protein and use in an assay for biologically-active cyclosporine |
| US5698448A (en) | 1988-12-02 | 1997-12-16 | Soldin; Steven J. | Immunosuppressive drug binding proteins and use |
| AU4958590A (en) | 1988-12-05 | 1990-07-10 | Trustees Of Columbia University In The City Of New York, The | Novel derivatives of cyclosporine a, antibodies directed thereto and uses thereof |
| AU4597489A (en) | 1988-12-09 | 1990-06-14 | G.D. Searle & Co. | Method for imparting immunosuppression |
| US5153327A (en) | 1988-12-23 | 1992-10-06 | E. R. Squibb & Sons, Inc. | 7-Oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease |
| US5100889A (en) | 1989-04-03 | 1992-03-31 | E. R. Squibb & Sons, Inc. | 7-oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease |
| GB2227244A (en) | 1989-01-19 | 1990-07-25 | Merck & Co Inc | Immunosuppressive fluorinated cyclosporin analogs |
| US5540931A (en) | 1989-03-03 | 1996-07-30 | Charles W. Hewitt | Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants |
| US4996193A (en) | 1989-03-03 | 1991-02-26 | The Regents Of The University Of California | Combined topical and systemic method of administration of cyclosporine |
| US5401731A (en) | 1989-06-29 | 1995-03-28 | Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Productionsaktieselskab) | Vitamin D analogues |
| EP0410176A1 (en) | 1989-07-07 | 1991-01-30 | Yoshitomi Pharmaceutical Industries, Ltd. | 2-Aminopentanoic acid compounds and their use as immunosuppressants |
| GB8915770D0 (en) | 1989-07-10 | 1989-08-31 | Leo Pharm Prod Ltd | Chemical compounds |
| US5665543A (en) | 1989-07-18 | 1997-09-09 | Oncogene Science, Inc. | Method of discovering chemicals capable of functioning as gene expression modulators |
| US5284826A (en) * | 1989-07-24 | 1994-02-08 | Sandoz Ltd. | 0-hydroxyethyl and acyloxyethyl derivatives of [ser]8 cyclosporins |
| GB8916901D0 (en) | 1989-07-24 | 1989-09-06 | Sandoz Ltd | Improvements in or relating to organic compounds |
| US5356633A (en) | 1989-10-20 | 1994-10-18 | Liposome Technology, Inc. | Method of treatment of inflamed tissues |
| CS277471B6 (cs) | 1989-11-16 | 1993-03-17 | Alexandr Rndr Csc Jegorov | Deriváty cyklosporinu A |
| CS277472B6 (cs) | 1989-11-16 | 1993-03-17 | Alexandr Rndr Csc Jegorov | Způsob výroby derivátů cyklosporinu A |
| US5514788A (en) | 1993-05-17 | 1996-05-07 | Isis Pharmaceuticals, Inc. | Oligonucleotide modulation of cell adhesion |
| US5591623A (en) | 1990-08-14 | 1997-01-07 | Isis Pharmaceuticals, Inc. | Oligonucleotide modulation of cell adhesion |
| US5129884A (en) * | 1990-01-16 | 1992-07-14 | Dysarz Edward D | Trap in barrel one handed retracted intervenous catheter device |
| US5270419A (en) | 1990-01-19 | 1993-12-14 | Nova Pharmaceutical Corporation | Polyanhydrides of oligomerized unsaturated aliphatic acids |
| US5171812A (en) | 1990-01-19 | 1992-12-15 | Nova Pharmaceutical Corporation | Polyanhydrides of oligomerized unsaturated aliphatic acids |
| US5122511A (en) | 1990-02-27 | 1992-06-16 | Merck & Co., Inc. | Immunosuppressive cyclosporin analogs with modified amino acids at position-8 |
| US5214130A (en) | 1990-02-27 | 1993-05-25 | Merck & Co., Inc. | Synthesis of novel immunosuppressive cyclosporin analogs with modified amino acids at position-8 |
| DE4013910A1 (de) | 1990-04-26 | 1991-10-31 | Schering Ag | Kombinationspraeparat zur immunsuppressiven therapie |
| US5385915A (en) | 1990-05-16 | 1995-01-31 | The Rockefeller University | Treatment of amyloidosis associated with Alzheimer disease using modulators of protein phosphorylation |
| DK0473961T3 (da) | 1990-08-15 | 1996-07-01 | Abbott Lab | Immunoassay-reagenser og fremgangsmåde til bestemmelse af cyklosporin |
| GB9017890D0 (en) | 1990-08-15 | 1990-09-26 | Leo Pharm Prod Ltd | Chemical compounds i |
| EP0547140A4 (en) | 1990-09-06 | 1993-10-13 | The Australian National University | Immunosuppressant composition |
| DK0484281T4 (da) | 1990-11-02 | 2001-02-05 | Novartis Ag | Cyclosporiner |
| EP0487289B1 (en) | 1990-11-20 | 1996-09-04 | BEHRINGWERKE Aktiengesellschaft | Cyclosporin immunoassay |
| EP0507968B1 (de) | 1991-04-06 | 1995-09-06 | Arzneimittelwerk Dresden Gmbh | Verfahren zur fermentativen Herstellung und Isolierung von Cyclosporin A sowie neue Cyclosporin- bildende Stämme |
| ZA923641B (en) | 1991-05-21 | 1993-02-24 | Iaf Biochem Int | Processes for the diastereoselective synthesis of nucleosides |
| US5578444A (en) | 1991-06-27 | 1996-11-26 | Genelabs Technologies, Inc. | Sequence-directed DNA-binding molecules compositions and methods |
| GB9113872D0 (en) | 1991-06-27 | 1991-08-14 | Sandoz Ag | Improvements in or relating to organic compounds |
| GB9116470D0 (en) | 1991-07-30 | 1991-09-11 | Erba Carlo Spa | 2-(imidazol-1-yl)-benzylethylidene-aminoxyalkanoic acid derivatives |
| US5571799A (en) | 1991-08-12 | 1996-11-05 | Basco, Ltd. | (2'-5') oligoadenylate analogues useful as inhibitors of host-v5.-graft response |
| WO1993003729A1 (en) | 1991-08-12 | 1993-03-04 | Research Corporation Technologies, Inc. | N-substituted phenoxazines for treating multidrug resistant cancer cells |
| US5972630A (en) * | 1991-08-19 | 1999-10-26 | Dade Behring Marburg Gmbh | Homogeneous immunoassays using enzyme inhibitors |
| US5217586A (en) | 1992-01-09 | 1993-06-08 | International Business Machines Corporation | Electrochemical tool for uniform metal removal during electropolishing |
| US5190972A (en) | 1992-01-27 | 1993-03-02 | The University Of Melbourne | Method of combatting cyclosporine organ toxicity with prostaglandin analogs |
| GB9204466D0 (en) * | 1992-03-02 | 1992-04-15 | Sandoz Ltd | Improvements in or relating to organic compounds |
| GB9206648D0 (en) | 1992-03-26 | 1992-05-06 | Leo Pharm Prod Ltd | Chemical compounds |
| US5527537A (en) | 1992-05-18 | 1996-06-18 | Dietl; Hans | Pharmaceutical preparation containing cyclosporine(s) for intravenous administration and a process for its production |
| US5637317A (en) | 1992-05-18 | 1997-06-10 | Dietl; Hans | Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing same |
| HU213553B (en) | 1992-05-25 | 1997-07-28 | Biogal Gyogyszergyar | Process for isolating of cyclosporin-a |
| AU4400593A (en) | 1992-06-05 | 1994-01-04 | Abbott Laboratories | Methods and reagents for the determination of immunosuppressive agents |
| CA2138542A1 (en) | 1992-06-23 | 1994-01-06 | Masaaki Ishizuka | New antibiotics having immunosuppressive activity, delaminomycins and processes for the production of the same |
| GB9214202D0 (en) | 1992-07-03 | 1992-08-12 | Leo Pharm Prod Ltd | Chemical compounds |
| EP0578616A3 (en) | 1992-07-09 | 1994-06-01 | Sandoz Ltd | Cylosporin synthetase |
| CZ278863B6 (en) | 1992-09-07 | 1994-07-13 | Galena | Medicinal preparations with n-methylated cyclic undecapeptides |
| GB9220439D0 (en) | 1992-09-28 | 1992-11-11 | Leo Pharm Prod Ltd | Chemical compounds |
| US5318895A (en) | 1992-10-05 | 1994-06-07 | Merck & Co., Inc. | Aspergillus niger mutants |
| US5589458A (en) | 1992-11-13 | 1996-12-31 | Thomas Jefferson University | Compounds that inhibit T cell proliferation and methods for using the same |
| US5298523A (en) | 1992-12-14 | 1994-03-29 | Harbor Branch Oceanographic Institution, Inc. | Method for treating transplant patients using mycalamide compounds |
| GB9226877D0 (en) | 1992-12-23 | 1993-02-17 | Leo Pharm Prod Ltd | Chemical compounds |
| CA2086267A1 (en) | 1992-12-24 | 1994-06-25 | Argyrios Margaritis | Cyclosporin derivatives and derivative conjugates |
| FI92334C (fi) | 1992-12-30 | 1994-10-25 | Leiras Oy | Menetelmä syklosporiinien tuottamiseksi ja menetelmässä käytettävä uusi Tolypocladium-kanta |
| US5393669A (en) | 1993-02-05 | 1995-02-28 | Martek Biosciences Corp. | Compositions and methods for protein structural determinations |
| US5834266A (en) | 1993-02-12 | 1998-11-10 | President & Fellows Of Harvard College | Regulated apoptosis |
| HUT73101A (en) | 1993-02-12 | 1996-06-28 | Harvard College | Method for regulating transcription of targeted genes and other biological events |
| US5650156A (en) | 1993-02-22 | 1997-07-22 | Vivorx Pharmaceuticals, Inc. | Methods for in vivo delivery of nutriceuticals and compositions useful therefor |
| US5665382A (en) | 1993-02-22 | 1997-09-09 | Vivorx Pharmaceuticals, Inc. | Methods for the preparation of pharmaceutically active agents for in vivo delivery |
| CN1245156C (zh) | 1993-02-22 | 2006-03-15 | 美国生物科学有限公司 | 用于体内传送生物制品的方法及用于该方法的组合物 |
| US5916596A (en) | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| US5665383A (en) | 1993-02-22 | 1997-09-09 | Vivorx Pharmaceuticals, Inc. | Methods for the preparation of immunostimulating agents for in vivo delivery |
| US5468772A (en) | 1993-03-10 | 1995-11-21 | Pharmagenesis, Inc. | Tripterinin compound and method |
| CA2161143A1 (en) | 1993-04-20 | 1994-10-27 | Monika Fleck | New pharmaceutical preparations comprising cyclosporin for oral administration |
| WO1994025606A2 (de) | 1993-04-23 | 1994-11-10 | Sandoz Ltd. | Rekombinante alanin racemase und gapdh aus tolypocladium niveum |
| EP0697879A4 (en) | 1993-05-04 | 1998-01-14 | Merck & Co Inc | AMINOALKYL ETHER DERIVATIVES OF CYCLOHEXAPEPTIDES |
| DE4338086A1 (de) | 1993-11-08 | 1995-05-11 | Dietl Hans | Cyclosporin(e) enthaltende pharmazeutische Zubereitung zur oralen Applikation sowie Verfahren zu ihrer Herstellung |
| AU7276594A (en) | 1993-08-13 | 1995-03-14 | Banyu Pharmaceutical Co., Ltd. | Endothelin-antagonistic cyclopentane derivative |
| ES2156157T3 (es) | 1993-08-18 | 2001-06-16 | Banyu Pharma Co Ltd | Derivado de ciclopenteno heteroaromatico fusionado con una actividad antagonista de la endotelina. |
| US5421987A (en) | 1993-08-30 | 1995-06-06 | Tzanavaras; George | Precision high rate electroplating cell and method |
| US5510239A (en) | 1993-10-18 | 1996-04-23 | Isis Pharmaceuticals, Inc. | Oligonucleotide modulation of multidrug resistance-associated protein |
| ES2148345T3 (es) | 1993-10-22 | 2000-10-16 | Hexal Ag | Composicion farmaceutica con ciclosporina a, un derivado de vitamina e y un emulsionante. |
| WO1995026325A2 (en) | 1994-03-25 | 1995-10-05 | Isotechnika Inc. | Enhancement of the efficacy of drugs by deuteration |
| JPH07278187A (ja) | 1994-04-07 | 1995-10-24 | Nippon Shinyaku Co Ltd | シクロスポリン類のリン酸エステル誘導体及び医薬組成物 |
| US5798386A (en) | 1994-08-03 | 1998-08-25 | Cell Therapeutics, Inc. | Angiogenic lipid formulations |
| US5948693A (en) | 1994-09-01 | 1999-09-07 | Wisconsin Alumni Research Foundation | Solid phase synthesis of immunosuppressive agents |
| US5639852A (en) | 1994-09-01 | 1997-06-17 | Wisconsin Alumni Research Foundation | Immunostimulatory agents |
| US5567300A (en) | 1994-09-02 | 1996-10-22 | Ibm Corporation | Electrochemical metal removal technique for planarization of surfaces |
| US5554725A (en) | 1994-09-14 | 1996-09-10 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Synthesis of dolastatin 15 |
| DE4433101A1 (de) | 1994-09-16 | 1996-03-21 | Bauer Kurt Heinz Prof Dr | Wasserlösliche Dextranfettsäureester und ihre Verwendung als Solubilisatoren |
| HU215966B (hu) | 1994-11-21 | 1999-07-28 | BIOGAL Gyógyszergyár Rt. | Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum |
| US5648376A (en) | 1995-01-19 | 1997-07-15 | Pharmagenesis, Inc. | Immunosuppressant diterpene compound |
| SE520730C2 (sv) | 1995-01-20 | 2003-08-19 | Eskil Elmer | Behandling av hjärnischemi och hjärnskador med ett neuroprotektivt läkemedel |
| IE75744B1 (en) | 1995-04-03 | 1997-09-24 | Elan Corp Plc | Controlled release biodegradable micro- and nanospheres containing cyclosporin |
| US5668734A (en) | 1995-04-10 | 1997-09-16 | The Uab Research Foundation | Method for analyzing 2D transferred noesy spectra of molecules undergoing multistate conformational exchange |
| US5965160A (en) | 1995-04-24 | 1999-10-12 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Self-emulsifiable formulation producing an oil-in-water emulsion |
| JP3934705B2 (ja) | 1995-05-26 | 2007-06-20 | ノバルティス ファーマ株式会社 | サイクロデキストリン組成物 |
| US5616595A (en) | 1995-06-07 | 1997-04-01 | Abbott Laboratories | Process for recovering water insoluble compounds from a fermentation broth |
| US5624902A (en) * | 1995-06-07 | 1997-04-29 | Torrey Pines Institute For Molecular Studies | Peptide inhibitors of calmodulin |
| DE19521974A1 (de) | 1995-06-16 | 1996-12-19 | Hexal Pharmaforschung Gmbh | Pharmazeutische Zubereitung mit Cyclosporin A |
| CN1141317C (zh) | 1995-07-17 | 2004-03-10 | 碳化学公司 | 有抗人体免疫缺损病毒作用的环孢菌素衍生物 |
| JPH0978187A (ja) | 1995-09-07 | 1997-03-25 | Daido Steel Co Ltd | メッキ用快削鋼 |
| GB9601120D0 (en) | 1996-01-19 | 1996-03-20 | Sandoz Ltd | Organic compounds |
| AU723905B2 (en) | 1996-03-12 | 2000-09-07 | Picower Institute For Medical Research, The | Treatment of HIV-infection by interfering with host cell cyclophilin receptor activity |
| US5840305A (en) | 1996-03-14 | 1998-11-24 | The Picower Institute For Medical Research | Treatment of HIV-Infection by interfering with host cell cyclophilin receptor activity |
| DE19611094C2 (de) | 1996-03-21 | 1999-06-17 | Dresden Arzneimittel | Verfahren zur Reinigung von Cyclosporin A und/oder verwandten Cyclosporinen aus einem Cyclosporin-haltigen Rohextrakt unter Anwendung chromatographischer Verfahren mit Kieselgel als Adsorbens |
| AUPN880396A0 (en) | 1996-03-21 | 1996-04-18 | Fremantle Hospital | Animal model for transplantation |
| JPH1029979A (ja) | 1996-04-12 | 1998-02-03 | Ajinomoto Co Inc | 新規ピリジン誘導体 |
| US5750510A (en) * | 1997-04-04 | 1998-05-12 | Abbott Laboratories | 3-descladinose-2,3-anhydroerythromycin derivatives |
| US5747330A (en) | 1996-06-05 | 1998-05-05 | Poli Industria Chimica | Antibiotic producing microbe |
| US5709797A (en) | 1996-06-05 | 1998-01-20 | Poli Industria Chimica S.P.A. | Method of isolating cyclosporins |
| CA2264718C (en) | 1996-09-01 | 2006-05-30 | Pharmos Corporation | Solid coprecipitates for enhanced bioavailability of lipophilic substances |
| GB9619894D0 (en) | 1996-09-24 | 1996-11-06 | Celltech Therapeutics Ltd | Pharmaceutical products |
| DE69732308T2 (de) | 1996-09-27 | 2005-06-02 | Jagotec Ag | Arzneistoffverabreichungssystem mit hyaluronsäure |
| JP2001505899A (ja) | 1996-12-12 | 2001-05-08 | デーデーエス ドラッグ デリバリー サービス ゲセルシャフト ツーア フェアデルング デア フォルシュング イン ファーマシューティッシャー テクノロジー ウント バイオファーマジー エムベーハー | 任意に活性物質を含むマトリクス材料−賦形剤コンパウンドの形態の処方物 |
| FR2757520B1 (fr) | 1996-12-24 | 1999-01-29 | Rhone Poulenc Rorer Sa | Derive de cyclosporine, sa preparation et les compositions pharmaceutiques qui le contiennent |
| FR2757521B1 (fr) | 1996-12-24 | 1999-01-29 | Rhone Poulenc Rorer Sa | Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent |
| FR2757522B1 (fr) | 1996-12-24 | 1999-01-29 | Rhone Poulenc Rorer Sa | Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent |
| US5843520A (en) | 1997-01-13 | 1998-12-01 | Vanguard International Semiconductor Corporation | Substrate clamp design for minimizing substrate to clamp sticking during thermal processing of thermally flowable layers |
| JPH10251137A (ja) | 1997-03-14 | 1998-09-22 | Advanced Sukin Res Kenkyusho:Kk | 光線過敏症抑制剤 |
| FR2762843B1 (fr) | 1997-04-30 | 1999-12-10 | Rhone Poulenc Rorer Sa | Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent |
| US5939406A (en) * | 1997-07-21 | 1999-08-17 | Wisconsin Alumni Research Foundation | 18-substituted-19-nor-vitamin D compounds |
| US6316405B1 (en) | 1997-08-26 | 2001-11-13 | Wisconsin Alumni Research Foundation | Cyclosporin a conjugates and uses therefor |
| US20030220234A1 (en) | 1998-11-02 | 2003-11-27 | Selvaraj Naicker | Deuterated cyclosporine analogs and their use as immunodulating agents |
| DK0991660T3 (da) | 1997-10-08 | 2006-02-13 | Isotechnika Inc | Deuterede og udeuterede cyclosporinanaloger og deres anvendelse som immunmodulerende midler |
| FR2772768B1 (fr) * | 1997-12-19 | 2000-01-14 | Rhone Poulenc Rorer Sa | Nouveau procede de preparation de derives de cyclosporine |
| US6706691B1 (en) | 1998-07-15 | 2004-03-16 | Board Of Regents, The University Of Texas System | Immunosupportive drug sparing diet |
| US6183611B1 (en) | 1998-07-17 | 2001-02-06 | Cutek Research, Inc. | Method and apparatus for the disposal of processing fluid used to deposit and/or remove material on a substrate |
| US6187152B1 (en) | 1998-07-17 | 2001-02-13 | Cutek Research, Inc. | Multiple station processing chamber and method for depositing and/or removing material on a substrate |
| FI110094B (fi) | 1999-09-10 | 2002-11-29 | Ecospec Ltd Oy | Menetelmä maanparannusaineen valmistamiseksi |
| CN1174741C (zh) | 1999-09-21 | 2004-11-10 | Rtp药品公司 | 生物活性物质的表面改性微粒组合物 |
| WO2001028519A1 (de) | 1999-10-20 | 2001-04-26 | Vesifact Ag | Mikroemulsion-prekonzentrate und mikroemulsionen |
| WO2003004469A1 (en) | 2001-07-02 | 2003-01-16 | Dabur Research Foundation | Anticancer activity of imino acid conjugates of methylglyoxal |
| PL210697B1 (pl) | 2001-10-19 | 2012-02-29 | Isotechnika Inc | Kompozycja zawierająca mieszaninę izomerów analogu cyklosporyny i zastosowanie tej mieszaniny |
| US7141648B2 (en) * | 2001-10-19 | 2006-11-28 | Isotechnika Inc. | Synthesis of cyclosporin analogs |
| US7012065B2 (en) | 2003-02-07 | 2006-03-14 | Enanta Pharmaceuticals, Inc. | Cyclosporins for the treatment of immune disorders |
| CA2518265A1 (en) | 2003-03-17 | 2004-09-30 | Albany Molecular Research, Inc. | Novel cyclosporins |
-
2002
- 2002-10-17 US US10/274,437 patent/US7141648B2/en not_active Expired - Lifetime
- 2002-10-17 AT AT06013976T patent/ATE425178T1/de active
- 2002-10-17 RU RU2004110940A patent/RU2321593C9/ru active
- 2002-10-17 KR KR1020047005699A patent/KR100982466B1/ko not_active Expired - Lifetime
- 2002-10-17 AT AT02767027T patent/ATE332917T1/de active
- 2002-10-17 PL PL370772A patent/PL210841B1/pl unknown
- 2002-10-17 KR KR1020097022767A patent/KR101006206B1/ko not_active Expired - Lifetime
- 2002-10-17 US US10/274,255 patent/US6998385B2/en not_active Ceased
- 2002-10-17 IL IL16076302A patent/IL160763A0/xx unknown
- 2002-10-17 PT PT06013976T patent/PT1714977E/pt unknown
- 2002-10-17 MX MXPA04003625A patent/MXPA04003625A/es active IP Right Grant
- 2002-10-17 BR BRPI0213658A patent/BRPI0213658A8/pt not_active Application Discontinuation
- 2002-10-17 HR HRP20040355AA patent/HRP20040355B1/hr not_active IP Right Cessation
- 2002-10-17 ES ES02767027T patent/ES2266564T3/es not_active Expired - Lifetime
- 2002-10-17 NZ NZ53194402A patent/NZ531944A/xx not_active IP Right Cessation
- 2002-10-17 DE DE60231570T patent/DE60231570D1/de not_active Expired - Lifetime
- 2002-10-17 WO PCT/CA2002/001559 patent/WO2003033526A2/en not_active Ceased
- 2002-10-17 PT PT02767027T patent/PT1436321E/pt unknown
- 2002-10-17 HR HRP20070058AA patent/HRP20070058B1/hr not_active IP Right Cessation
- 2002-10-17 EP EP20060013976 patent/EP1714977B1/en not_active Expired - Lifetime
- 2002-10-17 PL PL392749A patent/PL210795B1/pl unknown
- 2002-10-17 CA CA2461740A patent/CA2461740C/en not_active Expired - Lifetime
- 2002-10-17 JP JP2003536264A patent/JP4261355B2/ja not_active Expired - Lifetime
- 2002-10-17 CN CNB028207998A patent/CN100334106C/zh not_active Expired - Lifetime
- 2002-10-17 DE DE2002613115 patent/DE60213115T2/de not_active Expired - Lifetime
- 2002-10-17 ES ES06013976T patent/ES2326040T3/es not_active Expired - Lifetime
- 2002-10-17 SI SI200230376T patent/SI1436321T1/sl unknown
- 2002-10-17 AU AU2002331509A patent/AU2002331509B2/en not_active Expired
- 2002-10-17 EP EP20020767027 patent/EP1436321B9/en not_active Expired - Lifetime
- 2002-10-17 DK DK06013976T patent/DK1714977T3/da active
- 2002-10-17 DK DK02767027T patent/DK1436321T3/da active
-
2004
- 2004-03-05 IL IL160763A patent/IL160763A/en active IP Right Grant
- 2004-03-23 ZA ZA2004/02269A patent/ZA200402269B/en unknown
- 2004-03-26 MA MA27597A patent/MA27293A1/fr unknown
- 2004-04-16 TN TNP2004000068A patent/TNSN04068A1/en unknown
- 2004-04-19 CO CO04035670A patent/CO5580836A2/es not_active Application Discontinuation
- 2004-05-14 NO NO20042031A patent/NO332459B1/no not_active IP Right Cessation
-
2005
- 2005-04-28 US US11/118,830 patent/US7332472B2/en not_active Expired - Lifetime
-
2006
- 2006-07-27 CY CY20061101044T patent/CY1105111T1/el unknown
- 2006-10-13 US US11/549,575 patent/US20070087963A1/en not_active Abandoned
-
2007
- 2007-09-20 IL IL186140A patent/IL186140A/en active IP Right Grant
-
2008
- 2008-01-03 US US11/969,174 patent/US20080171850A1/en not_active Abandoned
- 2008-10-21 JP JP2008271446A patent/JP4887469B2/ja not_active Expired - Lifetime
-
2009
- 2009-09-08 US US12/555,787 patent/US20100062976A1/en not_active Abandoned
-
2010
- 2010-06-08 US US12/796,616 patent/US20100311944A1/en not_active Abandoned
- 2010-07-30 AU AU2010206069A patent/AU2010206069A1/en not_active Abandoned
- 2010-08-19 JP JP2010184229A patent/JP5396571B2/ja not_active Expired - Lifetime
-
2012
- 2012-11-26 US US13/684,574 patent/US20130078280A1/en not_active Abandoned
-
2013
- 2013-09-30 US US14/042,226 patent/US20140142277A1/en not_active Abandoned
-
2014
- 2014-06-30 US US14/320,408 patent/USRE48226E1/en not_active Expired - Lifetime
- 2014-07-04 US US14/324,146 patent/US20140370082A1/en not_active Abandoned
-
2015
- 2015-11-23 US US14/949,616 patent/US9765119B2/en not_active Expired - Fee Related
-
2017
- 2017-08-14 US US15/676,851 patent/US10472394B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL186140A0 (en) | Synthesis of cyclosporin analogs | |
| MY187182A (en) | Cyclosporine analogue mixtures and their use as immunomodulating agents | |
| DE60133047D1 (pl) | ||
| JO2034B1 (en) | Isotopes of the hormone peptide its uses and the chemical compounds it contains | |
| ATE245435T1 (de) | Totalsynthese des amino hip analogen von didemnin a | |
| CA2295483A1 (en) | Aliphatic propargylamines as cellular rescue agents | |
| YU33204A (sh) | Sinteza analoga ciklosporina | |
| YU33004A (sh) | Smeša analoga ciklosporina i njihova upotreba u svojstvu imunomodulatornih supstanci | |
| WO2001013895A3 (en) | Controlled-release sedative-hypnotic compositions and methods related thereto | |
| TW374693B (en) | Fungicidal mixtures | |
| CA2240205A1 (en) | Methods for improving the residual control of mites and prolonging the protection of plants from mite infestations | |
| RU2002129529A (ru) | Модифицирующая смесь | |
| CA2352275A1 (en) | Il-5 inhibiting 6-azauracil derivatives | |
| UY27523A1 (es) | Tetra-, penta-, hexa-y heptapéptidos con actividad antiangiogénica | |
| MY131116A (en) | Olefin polymerization catalyst composition comprising group 13 amide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RECP | Rectifications of patent specification | ||
| RECP | Rectifications of patent specification |